Prophylaxis Versus On-demand Therapy Through Economic Report
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The project is a controlled observational, multicenter, prospective data collection on
secondary prophylaxis with Kogenate Bayer in adolescents and adults with severe haemophilia A
(FVIII < 1%).
The observational period will cover at least 5 years per patient.
The long-term secondary prophylaxis group will be compared versus on-demand treatment group
by the assessment of orthopedic status progression and pharmacoeconomics evaluation.